Monday, December 7, 2020

Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...)

... phase I results from phase I/II study of Lentiviral-Mediated Ex-Vivo Gene Therapy for pediatric patients with severe Leukocyte Adhesion Deficiency-I ...
http://dlvr.it/Rn7TWL
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...